DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
April 9, 2024
NUROSENE ENTERS INTO AGREEMENT WITH TAYLORED BIOTHERAPEUTICS TO EVALUATE CLINICAL TRIAL RESULTS
June 22, 2022
Related Post
-
-
Cloud DX Announces Proposed $2.8 Million Private Placement
April 8, 2024
-
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
April 4, 2024
-
Healthcare Triangle Announces Strategic Partnership with Cynomi to Enhance Cybersecurity in Healthcare
April 4, 2024